RE: Good results - and a confident outlook30 Jul 2025 10:05
Bonkers initial price action, I assume due to traders on results taking losses.
Cavendish have retained their 7.1p EPS forecast and 140p target price, also pleasingly reducing their net debt forecast by £1.3m.
They summarise:
"FY25 results in line with FY26 forecasts reaffirmed
SDI reported FY25 results in-line with expectations, confirming stronger H2 demand after a weak H1, with a pickup in order intake in Q4. Revenue and profits have advanced significantly in H2, and margins have responded to operational drop through and internal efficiency measures. We make no changes to our FY26E forecasts and maintain our 140p target price based on an EV/EBITDA of 11.6x and P/E of 19.7x.
Despite recent share price out performance it stands on a compelling current P/E valuation of 12.1x, a 41% discount to Judges, despite Judges’ recent disappointing trading update. We see potential scope for EPS upgrades with an active pipeline of M&A opportunities, adding to the attractive organic investment proposition."
"— Forecasts: No change to our FY26E forecasts, except an improvement in net debt by £1.3m to £11.7m.
— Valuation: We maintain our target price at 140p, based on an EV/EBITDA of 11.6x and P/E of 19.7x. The shares have staged a significant rally, nearly doubling over the past six months, but remain at a 41% discount to Judges Scientific (despite its recent disappointing trading update and share price reaction) and the wider scientific instrument peer group.
The shares currently trade on an attractive FY26E P/E of 12.1x, and FCF yield of 8.3%, despite recent strong share price outperformance. With internal actions, accelerating organic growth and M&A activity we believe there is good scope for outperformance to continue."